STAMFORD, Conn., July 21 /PRNewswire-FirstCall/ — Zargis
Medical Corp., a majority-owned subsidiary of Speedus Corp.
(Nasdaq: SPDE), today announced that it received a
contract from the U.S. Army to develop an investigational device
based on the success of the Signal-X6™ telemedicine systems
recently deployed to the Army under a separate contract. Under the
terms of the new contract, Zargis will develop prototype versions
of the Signal-X6 system that will incorporate automated heart sound
detection and murmur classification functionality similar to that
offered by the award-winning Zargis Cardioscan software. This
$120,000 contract will commence on
August 1st, 2010.
Due to the fact that each Signal-X6 device incorporates six
acoustic sensors that simultaneously record sounds from a patient’s
torso, this new project will allow Zargis to enhance its
proprietary heart sounds analysis technology by leveraging
multi-channel heart sound input instead of relying on input from
the single sensor contained in a stethoscope.
“We are excited about this latest chapter in our ongoing
relationship with the U.S. Army,” stated Zargis CEO John Kallassy. “As our Signal-X6 systems
continue to be evaluated throughout the Army’s Military Treatment
Facilities, we anticipate that the integration of our heart sounds
analysis algorithms will lead the Army, and others, to deploy our
devices on a wider scale.”
Zargis expects that clinical data obtained regarding this
project will culminate in the development of an Army-sponsored
research paper.
The develo
‘/>”/>
